Two Sigma Investments, LP Obs Eva Sa Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.83 $24,798 - $324,153	177,133 New	177,133 $25,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $3.35 $80,384 - $105,190	-31,400 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.01 - $5.05 $23,717 - $59,590	11,800 Added 60.2%	31,400 $102,000
Q4 2020 Feb 16, 2021	BUY	$1.89 - $2.55 $37,044 - $49,980	19,600 New	19,600 $41,000
Q2 2020 Aug 14, 2020	SELL	$2.01 - $5.95 $115,574 - $342,125	-57,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.87 - $4.47 $57,409 - $137,229	30,700 Added 114.55%	57,500 $139,000
Q4 2019 Feb 14, 2020	BUY	$2.48 - $8.1 $66,464 - $217,080	26,800 New	26,800 $102,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.